Patents-Review.com
ClassID:

111676 ⎘

C12N2770/36134 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Togaviridae; Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260152728
2026-06-04

VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE

 #2
20260069677
2026-03-12

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES

 #3
20260041755
2026-02-12

ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF

 #4
20260034208
2026-02-05

VIRUS-LIKE VESICLES (VLVS) BASED VACCINES AND METHODS OF PREVENTING, AMELIORATING, AND/OR TREATING COVID-19 AND/OR HEPATOCELLULAR CARCINOMA (HCC)

 #5
20250381263
2025-12-18

Alphavirus (Mayaro virus) Constructs Attenuated for Human and Method of its Use

 #6
20250332239
2025-10-30

ANTIGENS FOR CANCER IMMUNOTHERAPY

 #7
20250326801
2025-10-23

VIRUS-LIKE PARTICLES AND METHODS OF USE

 #8
20250255952
2025-08-14

SELF-AMPLIFYING mRNA VACCINE BASED ON Z7 GENOME

 #9
20250228926
2025-07-17

RNA VACCINE LIPID NANOPARTICLES

 #10
20250213671
2025-07-03

NOVEL RNA AND DNA TECHNOLOGY FOR VACCINATION AGAINST ALPHAVIRUSES AND OTHER EMERGING AND EPIDEMIC VIRUSES

 #11
20250161434
2025-05-22

CORONAVIRUS VACCINE COMPOSITIONS AND METHODS

 #12
20250129342
2025-04-24

ALPHAVIRUS REPLICON PARTICLE

 #13
20250073326
2025-03-06

METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOGENIC CHIKUNGUNYA VIRUS CHIKV-DELTA5NSP3

 #14
20250032601
2025-01-30

METHODS OF MAKING AND USING UNIVERSAL CENTRALIZED INFLUENZA VACCINE GENES

 #15
20250027110
2025-01-23

COMPOSITIONS AND METHODS FOR INDUCING ESR1, PI3K, HER2, AND HER3 IMMUNE RESPONSES

 #16
20240417700
2024-12-19

Mammal-specific Growth-defective Arbovirus

 #17
20240398921
2024-12-05

VERSATILE VIRUS-LIKE-VESICLES (VLV) PLATFORM FOR INFECTIOUS DISEASES AND CANCER IMMUNOTHERAPY APPLICATIONS

 #18
20240390476
2024-11-28

ATTENUATED ALPHAVIRUS

 #19
20240390474
2024-11-28

COMPOSITIONS AND METHODS FOR THERAPEUTIC OR VACCINE DELIVERY

 #20
20240366745
2024-11-07

TROPICAL DISEASE VACCINES

 #21
20240350605
2024-10-24

TEMPERATURE-CONTROLLABLE, RNA IMMUNOTHERAPEUTIC FOR CANCER

 #22
20240335528
2024-10-10

EFFICIENT VACCINE

 #23
20240327865
2024-10-03

MODIFIED EASTERN EQUINE ENCEPHALITIS VIRUSES, SELF-REPLICATING RNA CONSTRUCTS, AND USES THEREOF

 #24
20240307520
2024-09-19

Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins

 #25
20240301007
2024-09-12

METHODS AND COMPOSITIONS FOR QUADRIVALENT INFLUENZA VACCINE

 #26
20240269259
2024-08-15

RABIES VIRUS VACCINE

 #27
20240269257
2024-08-15

INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION

 #28
20240216501
2024-07-04

NEOANTIGEN ADJUVANT AND MAINTENANCE THERAPY

 #29
20240167057
2024-05-23

MODIFIED ALPHAVIRUS VECTORS

 #30
20240115692
2024-04-11

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES

 #31
20240115691
2024-04-11

Coronavirus vaccine compositions and methods

 #32
20230398200
2023-12-14

MODIFIED CHIKUNGUNYA VIRUSES AND SINDBIS VIRUSES AND USES THEREOF

 #33
20230391833
2023-12-07

MODIFIED VACCINE DESIGN DEVELOPMENTS

 #34
20230381107
2023-11-30

Method of making lipid formulations with RNA encoding immunogens

 #35
20230381106
2023-11-30

Lipid formulations with RNA encoding immunogens

 #36
20230381105
2023-11-30

Immunisation with lipid formulations with RNA encoding immunogens

 #37
20230346910
2023-11-02

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

 #38
20230295242
2023-09-21

Virus-like particles and methods of use

 #39
20230293661
2023-09-21

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3

 #40
20230257775
2023-08-17

Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon

 #41
20230181714
2023-06-15

HUMAN MONOCLONAL ANTIBODIES TO VENEZUELAN EQUINE ENCEPHALITIS VIRUS AND USES THEREFOR

 #42
20230181706
2023-06-15

Fusion proteins comprising modified alpha virus surface glycoproteins and tumor associated antigen and methods thereof

 #43
20230174953
2023-06-08

DEFECTIVE INTERFERING VIRAL GENOMES

 #44
20230025038
2023-01-26

Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteins

 #45
20230020089
2023-01-19

SHARED NEOANTIGEN VACCINES

 #46
20220362152
2022-11-17

Vaccine for eliciting immune response comprising RNA encoding an immunogen and lipid formulations comprising mole percentage of lipids

 #47
20220347286
2022-11-03

INACTIVATED VACCINE FOR CHIKUNGUNYA VIRUS

 #48
20220347097
2022-11-03

Vaccine for eliciting immune response comprising lipid formulations and RNA encoding multiple immunogens

 #49
20220313810
2022-10-06

SINGLE SHOT CHIKUNGUNYA VIRUS VACCINE

 #50
20220298210
2022-09-22

Artificial alphavirus-derived RNA replicon expression systems

 #51
20220265820
2022-08-25

TUMOR IMMUNOTHERAPY USING SINDBIS VIRAL VECTORS AND AGONIST MONOCLONAL ANTIBODIES

 #52
20220244269
2022-08-04

Neutralizing antibody immunoassays

 #53
20220241395
2022-08-04

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

 #54
20220187298
2022-06-16

A METHOD OF IDENTIFYING A FLAVIVIRUS INFECTION, AND RELATED PEPTIDES, KITS AND COMPOSITIONS

 #55
20220153817
2022-05-19

Systems and Methods for the Production of Human Polyclonal Antibodies

 #56
20220125919
2022-04-28

ALPHAVIRUS NEOANTIGEN VECTORS AND INTERFERON INHIBITORS

 #57
20220125727
2022-04-28

Methods of administering lipid formulations with viral immunogens

 #58
20220125724
2022-04-28

Methods of administering lipid formulations with immunogens

 #59
20220125723
2022-04-28

Lipid formulations with viral immunogens

 #60
20220125722
2022-04-28

Lipid formulations with immunogens

 #61
20220024989
2022-01-27

Alphavirus nsP mutants as vaccines

 #62
20220016230
2022-01-20

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3

 #63
20220002682
2022-01-06

Alphavirus replicon particle

 #64
20210401983
2021-12-30

ARTHROGENIC ALPHAVIRUS VACCINE

 #65
20210388034
2021-12-16

Virus-like particles and methods of use

 #66
20210353738
2021-11-18

Methods of making and using universal centralized influenza vaccine genes

 #67
20210332088
2021-10-28

Multimerizing Polypeptides Derived From Jelly Roll Fold Domain of Adenovirus Penton Base

 #68
20210322534
2021-10-21

Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3

 #69
20210290756
2021-09-23

Coronavirus vaccine compositions and methods

 #70
20210290752
2021-09-23

Compositions and methods for inducing immune responses

 #71
20210252131
2021-08-19

COMPOSITIONS AND METHODS COMPRISING MEASLES VIRUS DEFECTIVE INTERFERING PARTICLES FOR THE PREVENTION OF INFECTIOUS DISEASES

 #72
20210222132
2021-07-22

Mammal-specific growth-defective arbovirus

 #73
20210205439
2021-07-08

Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine

 #74
20210196812
2021-07-01

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

 #75
20210187093
2021-06-24

Vaccine compositions

 #76
20210163988
2021-06-03

Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon

 #77
20210163544
2021-06-03

Stable cell line secreting Chikungunya Virus (CHIKV) virus like particles (VLP) for vaccines

 #78
20210077600
2021-03-18

Fusion proteins comprising modified alpha virus surface glycoproteins and tumor associated antigen and methods thereof

 #79
20200377598
2020-12-03

Induction and enhancement of antitumor immunity involving virus vectors expressing multiple epitopes of tumor associated antigens and immune checkpoint inhibitors or proteins

 #80
20200368344
2020-11-26

CHIKV RNA vaccines

 #81
20200297834
2020-09-24

Alphavirus and compositions, methods, and kits related thereto

 #82
20200289639
2020-09-17

Chikungunya virus RNA vaccines

 #83
20200289638
2020-09-17

Zika virus RNA vaccines

 #84
20200172930
2020-06-04

Chikungunya virus antigen constructs

 #85
20200108094
2020-04-09

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

 #86
20200085938
2020-03-19

Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins

 #87
20190359656
2019-11-28

Alphavirus NSP mutants as vaccines

 #88
20190316153
2019-10-17

Packaging cell for making a pseudotyped lentivirus

 #89
20190201520
2019-07-04

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

 #90
20190184003
2019-06-20

Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases

 #91
20190175720
2019-06-13

ZIKA VIRUS VACCINE AND COMBINATION VACCINE

 #92
20190153041
2019-05-23

Virus-like particles and methods of use

 #93
20190134197
2019-05-09

Arthrogenic alphavirus vaccine

 #94
20190134184
2019-05-09

Zika viral antigen constructs

 #95
20190134182
2019-05-09

Compositions and methods for live, attenuated alphavirus formulations

 #96
20190111124
2019-04-18

Compositions and methods for stabilizing alphaviruses with improved formulations

 #97
20190106682
2019-04-11

Live, Attenuated Alphavirus Constructs and Methods and Uses Thereof

 #98
20190091329
2019-03-28

Cationic oil-in-water emulsions

 #99
20190060438
2019-02-28

Infectious disease vaccines

 #100
20190054161
2019-02-21

INACTIVATED VACCINE FOR CHIKUNGUNYA VIRUS

 #101
20190038739
2019-02-07

Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine

 #102
20190031722
2019-01-31

Modified Zika virus NS1 protein with reduced cross-reactive immunogenicity

 #103
20190008947
2019-01-10

Chikungunya virus RNA vaccines

 #104
20190008946
2019-01-10

Zika virus RNA vaccines

 #105
20180371494
2018-12-27

T7 alpha viral vector system

 #106
20180344839
2018-12-06

CHIKV RNA vaccines

 #107
20180280496
2018-10-04

Zika RNA vaccines

 #108
20180243404
2018-08-30

iDNA vaccines and methods for using the same

 #109
20180243389
2018-08-30

Fusion proteins comprising modified alpha virus surface glycoproteins and tumor associated antigen and methods thereof

 #110
20180179555
2018-06-28

Methods of delivering a pseudotyped lentivirus

 #111
20180008694
2018-01-11

Chikagunya virus RNA vaccines

 #112
20180008690
2018-01-11

Nanocapsules carrying chikungunya-associated peptides

 #113
20170340724
2017-11-30

Zika virus RNA vaccines

 #114
20170240919
2017-08-24

Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

 #115
20170233459
2017-08-17

Systems and methods for the production of human polyclonal antibodies

 #116
20170233450
2017-08-17

Virus like particle comprising PD-1 antigen or PD-1 ligand antigen

 #117
20170202960
2017-07-20

Cationic oil-in-water emulsions

 #118
20170073377
2017-03-16

Virus-like particles and methods of use

 #119
20170067027
2017-03-09

Recombinant isfahan viral vectors

 #120
20170065703
2017-03-09

Method and composition for modulating immune response

 #121
20170051307
2017-02-23

Evolution of high-titer virus-like vesicles for vaccine applications

 #122
20170049877
2017-02-23

West Nile Virus vaccine

 #123
20170035871
2017-02-09

MALARIA VACCINE

 #124
20170014502
2017-01-19

Vaccine compositions

 #125
20160375121
2016-12-29

Engineered vesicles comprising antigenic peptides and the uses thereof as modulators of immune responses

 #126
20160348132
2016-12-01

TC-83-derived alphavirus vectors, particles and methods

 #127
20160340692
2016-11-24

Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein

 #128
20160303221
2016-10-20

Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteins

 #129
20160281095
2016-09-29

Alkynyl-derivatized cap analogs, preparation and uses thereof

 #130
20160200775
2016-07-14

Virus like particle comprising modified envelope protein E3

 #131
20160145323
2016-05-26

Antibodies against chikungunya virus and uses thereof

 #132
20160090403
2016-03-31

Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein

 #133
20160074500
2016-03-17

Infectious DNA vaccines against chikungunya virus

 #134
20160040134
2016-02-11

Virus like particle comprising modified envelope protein E3

 #135
20150238592
2015-08-27

Recombinant measles virus expressing chikungunya virus polypeptides and their applications

 #136
20150232515
2015-08-20

Salmonid alphavirus and uses thereof

 #137
20150182636
2015-07-02

Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

 #138
20150175975
2015-06-25

Alphavirus compositions and methods of use

 #139
20150175667
2015-06-25

Method of stimulating an immune response using a pseudotyped lentivirus

 #140
20150056230
2015-02-26

Equine encephalitis virus vaccines and methods of using thereof

 #141
20150017194
2015-01-15

Virus like particle comprising PD-1 antigen or PD-1 ligand antigen

 #142
20140328877
2014-11-06

West Nile Virus vaccine

 #143
20140271715
2014-09-18

Compositions and methods for live, attenuated alphavirus formulations

 #144
20140242114
2014-08-28

cDNA construct of Salmonidae alphavirus

 #145
20140220083
2014-08-07

Cationic oil-in-water emulsions

 #146
20140178430
2014-06-26

IDNA vaccines and methods for using the same

 #147
20140170186
2014-06-19

Virus-like particles and methods of use

 #148
20140120125
2014-05-01

Inactivated chikungunya viruses (CHIKV) comprising an E1-K211E mutation

 #149
20140086953
2014-03-27

Attenuated Chikungunya virus

 #150
20140079734
2014-03-20

Methods and compositions for alphavirus replicons

 #151
20140065178
2014-03-06

Methods and compositions for pseudoinfectious alphaviruses

 #152
20140010841
2014-01-09

Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

 #153
20130337007
2013-12-19

Salmonid alphavirus protein E2

 #154
20130316434
2013-11-28

Animal protein free media for cultivation of cells

 #155
20130251744
2013-09-26

Virus like particle composition

 #156
20130058971
2013-03-07

INNOCULATION OF RECOMBINANT VIRAL VECTORS FOR RAPID PRE-EXPOSURE PREVENTION AND POST-EXPOSURE PROTECTION AGAINST ALPHAVIRUS-INDUCED ENCEPHALITIDES

 #157
20130052225
2013-02-28

Infectious DNA vaccines against chikungunya virus

 #158
20130022631
2013-01-24

Vaccine for chikungunya virus infection

 #159
20120100181
2012-04-26

Attenuation of encephalitogenic alphavirus and uses thereof

 #160
20120070462
2012-03-22

Targeted gene delivery to dendritic cells

 #161
20120003266
2012-01-05

Virus-like particles (VLPs) prepared from chikungunya virus structural proteins

 #162
20110243989
2011-10-06

IDNA vaccines and methods for using the same

 #163
20110217772
2011-09-08

Animal protein free media for cultivation of cells

 #164
20110182941
2011-07-28

Alphavirus and alphavirus replicon particle formulations and methods

 #165
20110177023
2011-07-21

Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

 #166
20110159033
2011-06-30

West Nile Virus vaccine

 #167
20110135659
2011-06-09

Fish vaccine

 #168
20110064767
2011-03-17

CDNA CONSTRUCT OF SALMONIDAE ALPHAVIRUS

 #169
20110052634
2011-03-03

Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

 #170
20110027306
2011-02-03

TC-83-derived alphavirus vectors, particles and methods

 #171
20110014233
2011-01-20

Psoralen-inactivated viral vaccine and method of preparation

 #172
20100322965
2010-12-23

VIRAL VACCINE VECTORS

 #173
20100209451
2010-08-19

Compositions and Methods Related to Adenovirus Based Delivery of Antigens

 #174
20100183665
2010-07-22

Promoterless cassettes for expression of alpha virus structural proteins

 #175
20100120140
2010-05-13

Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN

 #176
20100120122
2010-05-13

Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein

 #177
20100047274
2010-02-25

Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alpha-virus-induced encephalitides

 #178
20100015179
2010-01-21

Attenuation of encephalitogenic alphavirus and uses thereof

 #179
20090304745
2009-12-10

Chimeric alphavirus replicon particles

 #180
20090162388
2009-06-25

Fish vaccine

 #181
20090075384
2009-03-19

Promoterless cassettes for expression of alphavirus structural proteins

 #182
20090047255
2009-02-19

Alphavirus and Alphavirus Replicon Particle Formulations and Methods

 #183
20080317777
2008-12-25

cDNA construct of salmonidae alphavirus

 #184
20080260698
2008-10-23

Chimeric sindbis-western equine encephalitis virus and uses thereof

 #185
20080213309
2008-09-04

Multi-antigenic alphavirus replicon particles and methods

 #186
20080019998
2008-01-24

Targeted gene delivery for dendritic cell vaccination

 #187
20070231350
2007-10-04

West Nile vaccine

 #188
20070231349
2007-10-04

West nile DNA vaccine

 #189
20070178119
2007-08-02

Methods for preventing or ameliorating West Nile encephalitis

 #190
20070166802
2007-07-19

Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine

 #191
20070166326
2007-07-19

West Nile vaccine

 #192
20070166325
2007-07-19

West Nile vaccine

 #193
20070166324
2007-07-19

West Nile vaccine

 #194
20070141617
2007-06-21

Enveloped virus vaccine and method for production

 #195
20060292175
2006-12-28

Chimeric alphavirus replicon particles

 #196
20060222660
2006-10-05

Use of DNA vaccine in combination with a conventional vaccine to overcome immunogen interference

 #197
20060045888
2006-03-02

Antigen library immunization

 #198
20050266550
2005-12-01

TC-83-derived alphavirus vectors, particles and methods

 #199
20050221493
2005-10-06

Recombinant virus production for the manufacturing of vaccines

 #200
20050208020
2005-09-22

Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines

 #201
20050118251
2005-06-02

DNA-based vaccine against the encephalitis alphaviruses

 #202
17720002
2023-08-22

Compositions and methods for the prevention and treatment of rabies virus infection

 #203
17590166
2025-09-30

Alphavirus immunogens and methods of use